IDEVvsPPH
iShares Core MSCI International Developed Markets ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | PPH | |
|---|---|---|
| Expense ratio | 0.040% | 0.36% |
| Assets | $32.2B | $1B |
| Net flow, 1 month | +$892M | +$44M |
| Net flow, 1 year | +$7.3B | +$325M |
| Return, YTD | +8.6% | +4.7% |
| Return, 1 year | +10.9% | +15.8% |
| Avg daily volume | 1.9M | 286K |
| Holdings | 2281 | 27 |
| Listed | Mar 21, 2017 | Feb 1, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS